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Abstract
Twenty Alzheimer’s disease (AD) patients, 20 subcortical ischemic vascular dementia (SIVD) patients and 20 neurologically and
cognitively normal subjects underwent transcranial magnetic stimulation to study motor cortex excitability changes. Motor threshold (MT),
amplitude of motor evoked potentials, silent period and the H/M ratio (amplitude of maximal Hoffman reflex vs. that of maximal motor
response) were considered. MT was lower in SIVD patients when compared with AD patients (P ¼ 0:003) and the control group (P , 0:001)
and lower in AD patients when compared with the control group (P , 0:001). The increment of motor cortex excitability in AD and SIVD
did not lead us to distinguish clearly the two types of dementia. It is likely that the electrophysiological similarity between AD and SIVD
could represent another common mechanism shared from these forms of dementia.
q 2004 Elsevier Ireland Ltd. All rights reserved.
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Alzheimer’s disease (AD) and vascular dementia (VaD) are
the two most common forms of dementia, which share many
pathological, symptomatic and neurochemical features [10].
Subcortical ischemic vascular dementia (SIVD) represents an
important and homogeneous subtype of VaD [5]. Transcranial
magnetic stimulation (TMS) is the method of choice for non-
invasive stimulation of human brain in conscious subjects. It
represents a valid tool to study the motor cortex excitability
through the evaluation of the motor threshold (MT). In the last
years, MT has been investigated in AD patients [1,15,17] but
there are no reports available on motor cortex excitability in
VaD patients.
In the present work, motor cortex excitability changes
were studied in AD and SIVD patients to assess the
electrophysiological differentiation and the eventual useful-
ness of MT for a better clinical evaluation of these two types
of dementia.
Twenty SIVD patients (eight men, 12 women, age range
48–84 years, mean age 71.8 ^ 9.37 years), 20 AD patients
(seven men, 13 women, age range 55–82 years, mean age
72.2 ^ 7.53 years) and 20 neurologically and cognitively
intact subjects (eight men and 12 women, age range 52–80
years, mean age 68.55 ^ 7.96 years) were studied. The study
was approved by the local ethics committee and informed
consent was obtained from all patients (or from close relatives)
and control subjects. All patients and control subjects were
free of acetylcholinesterase inhibitors or other medications
able to induce cortical or spinal excitability changes. The
diagnosis of probable SIVD was established on a modification
[5] of the NINDS-AIREN (National Institute for Neurological
Disorders and Stroke–Association Internationale pour la
Recherche et l’Enseignement en Neuroscience) criteria for
probable VaD [18], while the diagnosis of probable AD was
established following the criteria of the National Institute of
Neurological and Communicative Disorders and Stroke–
Alzheimer Disease and Related Disorders Association
(NINCDS-ADRDA) [12]. All the patients underwent a
magnetic resonance imaging (MRI) study. SIVD patients
were included if their cerebral MRI showed subcortical
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lacunes and/or a multiple involvement of the inner white
matter. Patients with AD were excluded from the study if they
had lacunes or other major pathologies such as brain tumors,
hydrocephalus, and trauma, except cortical atrophy. More-
over, AD patients were excluded if their neurological
examination showed motor disturbances. Included SIVD
patients had no clinical history of stroke. They showed
executive frontal lobe dysfunction; in some SIVD patients, the
clinical examination showed some neurological signs such as
dysarthria, gait disturbances, urinary incontinence, asym-
metric tendon reflexes or hemisensory deficit. None of the
patients had a history of epilepsy, clinical evidence of
myoclonus or extrapyramidal signs. Moreover, they were
excluded in the case of reduced hand or upper limb motor
strength. Hand motor strength was evaluated by means of a
rating scale derived from the Medical Research Council
(MRC) scale. All patients showed a normal hand strength
score (MRC ¼ 5). An additional inclusion criterion was the
finding of motor evoked potentials (MEPs) with normal
latency, amplitude and symmetry in both hands. Moreover,
patients were excluded if they were unable to respond to
simple orders.
Surface recording electrodes were placed over the first
dorsal interosseus (FDI) muscle. Magnetic stimulation was
performed using a Magstim 200 stimulator (Magstim Ltd.,
Withland Dyfed, UK) connected to a 9 cm mean diameter
circular coil. Resting MT was defined as the lowest TMS
intensity able to induce motor responses of an amplitude.20
mV in the relaxed contralateral target muscle, according to
internationally established parameters [19]. Cortical stimu-
lation was performed with the coil placed tangentially to the
scalp and lateralized on the examined hemisphere with the
handle held backward. Stimulation was applied at the ‘hot
spot’ (i.e. the scalp position from which a contralateral MEP of
maximal amplitude, minimal latency and lowest threshold was
obtained), according to Rossini et al. [19].
Stimulus intensity was set at 30% above the threshold
level. The left hemisphere was stimulated by a counter-
clockwise current and the right hemisphere by a clockwise
current. MEPs were amplified using a Medelec Premier
(Oxford Instruments) system with gains of 100 mV and 5
mV/div (band pass 30 Hz to 3 kHz). Subjects were studied
while producing a weak contraction of the recorded muscle
and a post-stimulus period of 100 ms was analyzed. Peak-to-
peak amplitudes were measured and five consecutive
responses were averaged. The silent period (SP) was
estimated as the time between the end of the MEP and the
recovery of voluntary activity [9]. It was determined with an
approximately 50% of maximum isometric voluntary
contraction of the FDI muscle monitored by an acoustic
feedback via a loudspeaker and visually on an oscilloscope.
The TMS intensity was set at 30% above resting MT. In
each experimental condition, the mean SP duration of the
five trials was calculated. The analysis time was 500 ms.
In 6/20 SIVD patients, 5/20 AD patients and 5/20 normal
subjects it was possible to measure the H/M ratio (amplitude
of maximal Hoffman reflex vs. that of the maximal motor
response) to examine the spinal motoneurons excitability.
The FDI H reflex was evoked from both sides by ulnar nerve
stimulation, while the subjects performed a mild contraction
of the target muscle. The stimulation was a constant current
given at the wrist with the cathode positioned proximally,
with an intensity below the threshold for M response
appearance. The rate of stimulation was 1 Hz and the
stimulus was a square pulse of 0.5 ms. The comparison of
the values of the different parameters measured in this study
obtained in the three groups of subjects was performed by
means of a one-way analysis of variance (ANOVA)
followed by post-hoc between-group comparisons when
the ANOVA was statistically significant. Values of P lower
than 0.05 were considered as statistically significant.
Results were expressed as mean ^ 2.5 standard deviation
(SD).
The electrophysiological data obtained from AD patients
have been reported in Table 1. No significant interside
differences were found in the three groups for each TMS
parameter and no statistically significant differences were
found in the H/M ratio between patients and normal
controls. The mean resting MT was 36 ^ 3.02% in AD
patients, 32.7 ^ 2.61% in SIVD patients and 49.1 ^ 4.21%
in the control group.
The mean MEP/Mmax values were 48.9 ^ 9.83% in AD
patients, 51.9 ^ 13.57% in SIVD patients and
43.7 ^ 8.93% in the control group. The mean values of
SP duration were 123.8 ^ 36.33 ms in AD patients,
148.7 ^ 46.41 ms in SIVD patients and 149.8 ^ 43.57 ms
in normal subjects.
The ANOVA showed statistically significant differences
for MT. In particular, MT was lower in both patient groups
than in normal controls (P , 0:001) and SIVD patients
showed values significantly lower than those of AD subjects
(P , 0:01). The ANOVA did not disclose significant group
differences for the remaining parameters considered in this
study; however, there was a tendency for MEP/Mmax in both
patient groups to show values higher than those of normal
controls.
MT was significantly decreased in patients (AD and
SIVD) compared to cognitively normal subjects. These
findings in AD patients confirm and support the previous
reports [1,11,15,17]. The hyperexcitability is not due to
aging, and in fact it has been shown as an increment of MT
in elderly adults when compared with young subjects [14,
20]. It could be associated with the neurodegeneration
mediated by an abnormal glutamate mechanism [7,8].
Glutamate is the principal excitatory neurotransmitter in
the brain. Overstimulation of the N-methyl-D-aspartate
(NMDA) receptors by glutamate (‘excitotoxicity’) is
implicated in a variety of pathologic conditions, ranging
from acute insult such as stroke to chronic neurodegenera-
tive disorders such as Huntington’s disease, the acquired
immunodeficiency syndrome (AIDS) dementia complex,
amyotrophic lateral sclerosis [3] and AD [13]. On the other
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hand, motor cortex hyperexcitability does not appear to be
due to decreased GABAergic intracortical inhibitory
circuits [7], because they have been shown to be normal
in AD patients by Pepin et al. [17] using paired TMS. In
SIVD patients, caudate nucleus, globus pallidus, parame-
dian and anterior nuclei of the thalamus and connecting
fibers of the frontal subcortical circuits are frequently
affected [4]. In these patients, the cognitive alterations were
suggested to be the consequence of the disconnections of the
executive frontal circuits, due to strategic infarcts. Micro-
infarction is an important substrate for the development of
dementia [2], but CVD (cerebrovascular disease), present in
SIVD patients, cannot explain cortical hyperexcitability in
this group of patients. In fact, Pennisi et al. [16] showed that
a strategic lacunar infarct in the pyramidal tract often
reduces corticospinal excitability, despite complete clinical
recovery. So, also in SIVD patients, the increased
excitability could probably be ascribed to a dysregulation
in excitatory or inhibitory circuits. Deficits in cholinergic
neuronal markers and degeneration of neuronal circuits
could contribute to cognitive decline in VaD patients, like in
AD [6]. Liepert et al. [11] showed that motor cortex
disinhibition can be transiently corrected by cholinesterase
inhibitor drugs, but 1 year of treatment did not stop the
progressive increase in motor cortex excitability [15]. The
impaired cholinergic neurotransmission in AD and VaD
could represent a neurochemical overlap in patients with
dementia. In SIVD, we cannot exclude the involvement of
GABAergic intracortical inhibitory circuits because no
studies with paired TMS have been reported so far. The
reduced MT could be due to increased spinal motoneurons
excitability, but in the present work we showed an
insignificant difference in the H/M amplitude ratio amongst
AD, SIVD and control subjects.
In the present study, the SP was not different in both
groups of patients when compared with normal subjects. SP
showed a negative correlation with aging, which could be
partially explained by the tendency for a higher MT in older
people [9]. The early part of the SP is probably due to the
spinal mechanism, while the latter part could be mediated
by cortical structures, probably by stimulation of GABA-
ergic intracortical inhibitory circuits. A previous study [17]
showed that GABAergic intracortical inhibition was normal
in AD, without any data about SIVD patients.
In conclusion, our data about the increment of motor
cortex excitability in AD and SIVD did not lead to a clear
distinction between the two types of dementia. The
electrophysiological similarity could represent another
common mechanism shared from these two forms of
dementia or it could support the concept that AD and VaD
are not mutually exclusive disorders.
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